Federated Hermes, Inc. Scynexis Inc Transaction History
Federated Hermes, Inc.
- $43 Billion
- Q4 2024
A detailed history of Federated Hermes, Inc. transactions in Scynexis Inc stock. As of the latest transaction made, Federated Hermes, Inc. holds 2,895,000 shares of SCYX stock, worth $3.21 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,895,000
Previous 3,595,000
19.47%
Holding current value
$3.21 Million
Previous $5.36 Million
37.85%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding SCYX
# of Institutions
53Shares Held
12.7MCall Options Held
9KPut Options Held
0-
Kingdon Capital Management, L.L.C. New York, NY2.24MShares$2.48 Million0.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.66MShares$1.84 Million0.0% of portfolio
-
Avidity Partners Management LP Dallas, TX1.23MShares$1.36 Million0.16% of portfolio
-
Amh Equity LTD626KShares$694,9170.79% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC556KShares$616,6660.7% of portfolio
About SCYNEXIS INC
- Ticker SCYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 32,651,800
- Market Cap $36.2M
- Description
- SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...